Literature DB >> 23414481

Health-related resource use and costs in elderly adults with and without mild cognitive impairment.

Carolyn W Zhu1, Mary Sano, Steven H Ferris, Peter J Whitehouse, Marian B Patterson, Paul S Aisen.   

Abstract

OBJECTIVES: To assess differences in resource use and cost between older adults with and without mild cognitive impairment (MCI) over time.
DESIGN: Multicenter, longitudinal study.
SETTING: Sixty-eight Alzheimer's Disease Cooperative Study (ADCS) sites in the United States. PARTICIPANTS: Two hundred fifty-nine individuals diagnosed with MCI and 107 cognitively normal elderly adults followed annually for 3 years. MEASUREMENTS: The Resource Use Instrument (RUI) was used to capture medical and nonmedical care use. Generalized linear latent and mixed models were used to estimate differences in resource use and costs in older adults with and without MCI after controlling for clinical and demographic characteristics.
RESULTS: At baseline, average annual direct medical cost per person was substantially higher for participants with MCI ($6,499) than for those without ($2,969) P < .001). Informal care use was also substantially higher (33% vs 8.4%, P < .001). Results from multivariate analyses of longitudinal data show that, after controlling for participant and informant characteristics, direct medical costs were 44% higher for participants with MCI than for those without. Participants with MCI were almost five times as likely to use informal care as those without. Number of medical conditions and older age were associated with higher medical cost. Worse functional and cognitive status, older age, being married, and being female were associated with higher likelihood of informal care use. Having an adult child informant was associated with higher likelihood of using informal care.
CONCLUSION: The RUI captured differences in resource use and costs between individuals with and without MCI. Clinicians who care for individuals with MCI should address informal care needs early in the disease course.
© 2013, Copyright the Authors Journal compilation © 2013, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2013        PMID: 23414481      PMCID: PMC3928966          DOI: 10.1111/jgs.12132

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  27 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Participation in clinical trials and long-term outcomes in Alzheimer's disease.

Authors:  S M Albert; M Sano; K Marder; D M Jacobs; J Brandt; M Albert; Y Stern
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

3.  Eligibility of Alzheimer's disease clinic patients for clinical trials.

Authors:  L S Schneider; J T Olin; S A Lyness; H C Chui
Journal:  J Am Geriatr Soc       Date:  1997-08       Impact factor: 5.562

4.  An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  D Galasko; D Bennett; M Sano; C Ernesto; R Thomas; M Grundman; S Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

5.  Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Authors:  R C Mohs; D Knopman; R C Petersen; S H Ferris; C Ernesto; M Grundman; M Sano; L Bieliauskas; D Geldmacher; C Clark; L J Thal
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.

Authors:  Mary Sano; Carolyn W Zhu; Peter J Whitehouse; Steven Edland; Shelia Jin; Karin Ernstrom; Ronald G Thomas; Leon J Thal; Steven H Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

8.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

9.  Direct costs associated with mild cognitive impairment in primary care.

Authors:  Melanie Luppa; Sven Heinrich; Herbert Matschinger; Anke Hensel; Tobias Luck; Steffi G Riedel-Heller; Hans-Helmut König
Journal:  Int J Geriatr Psychiatry       Date:  2008-09       Impact factor: 3.485

10.  Validating California teachers study self-reports of recent hospitalization: comparison with California hospital discharge data.

Authors:  Sarah F Marshall; Dennis Deapen; Mark Allen; Hoda Anton-Culver; Leslie Bernstein; Pamela L Horn-Ross; David Peel; Rich Pinder; Peggy Reynolds; Ronald K Ross; Dee West; Al Ziogas
Journal:  Am J Epidemiol       Date:  2003-11-15       Impact factor: 4.897

View more
  22 in total

1.  Associations Between Mild Cognitive Impairment and Hospitalization and Readmission.

Authors:  Kathryn E Callahan; James F Lovato; Michael E Miller; Doug Easterling; Beth Snitz; Jeff D Williamson
Journal:  J Am Geriatr Soc       Date:  2015-08-27       Impact factor: 5.562

2.  The Moderating Effect of Personality Type on the Relationship between Leisure Activity and Executive Control in Older Adults.

Authors:  Nikki L Hill; Feng Vankee Lin; Jeanine M Parisi; Ann Kolanowski
Journal:  Act Adapt Aging       Date:  2015-01-24

3.  Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study.

Authors:  Cynthia L Leibson; Kirsten Hall Long; Jeanine E Ransom; Rosebud O Roberts; Steven L Hass; Amy M Duhig; Carin Y Smith; Jane A Emerson; V Shane Pankratz; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2015-04-06       Impact factor: 21.566

4.  Medical and nursing home costs: From cognitively unimpaired through dementia.

Authors:  Kirsten Hall Long; Carin Smith; Ronald Petersen; Jane Emerson; Jeanine Ransom; Michelle M Mielke; Steven Hass; Cynthia Leibson
Journal:  Alzheimers Dement       Date:  2021-09-05       Impact factor: 21.566

5.  Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults.

Authors:  Robert J Dawe; Lei Yu; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Patricia A Boyle
Journal:  Neurobiol Aging       Date:  2018-05-23       Impact factor: 4.673

6.  Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia.

Authors:  Jennifer C Davis; Stirling Bryan; Carlo A Marra; Ging-Yuek R Hsiung; Teresa Liu-Ambrose
Journal:  Br J Sports Med       Date:  2013-11-06       Impact factor: 13.800

7.  Moving Towards a More Comprehensive Investigation of Racial/Ethnic Differences in Cognitive Disability Among US Adults.

Authors:  Emma K T Benn; Ashley Fox; Kezhen Fei; Eric Roberts; Bernadette Boden-Albala
Journal:  J Immigr Minor Health       Date:  2015-08

Review 8.  Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations.

Authors:  Tuoyo O Mene-Afejuku; Monica Pernia; Uzoma N Ibebuogu; Shobhana Chaudhari; Savi Mushiyev; Ferdinand Visco; Gerald Pekler
Journal:  Curr Cardiol Rev       Date:  2019

9.  Cognitive impairment no dementia and associations with health literacy, self-management skills, and functional health status.

Authors:  Rebecca M Lovett; Laura M Curtis; Stephen D Persell; James W Griffith; Derin Cobia; Alex Federman; Michael S Wolf
Journal:  Patient Educ Couns       Date:  2020-03-12

10.  Inflammatory potential of diet is associated with cognitive function in an older adult Korean population.

Authors:  Dayeon Shin; Simona C Kwon; Mi Hye Kim; Kyung Won Lee; Soe Yeon Choi; Nitin Shivappa; James R Hébert; Hae-Kyung Chung
Journal:  Nutrition       Date:  2018-03-27       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.